In terms of technology, 15.6% of patients using an insulin pump and 24.5% of those on multi-injection therapy were diagnosed with DN (Table 4); of these patients, 13.6% (n = 11) were diagnosed with DPN specifically, 15.2% of males (n = 7) and 11.4% of females (n = 4)—18.8% (n = 6) of patients aged 17–20 compared to 10.2 of patients aged 11–16, and 21.9% (n = 7) of those with more than 10 years of diabetes compared to 8.2% of those with less than 10 years (Table 4). The gene discussed is INS; the disease is liver dysplastic nodule.